105 related articles for article (PubMed ID: 11485409)
21. Dispensability of Jak1 tyrosine kinase for interleukin-2-induced cell growth signaling in a human T cell line.
Higuchi M; Asao H; Tanaka N; Oda K; Takeshita T; Nakamura M; Van Snick J; Sugamura K
Eur J Immunol; 1996 Jun; 26(6):1322-7. PubMed ID: 8647212
[TBL] [Abstract][Full Text] [Related]
22. Cutting edge: TCR stimulation by antibody and bacterial superantigen induces Stat3 activation in human T cells.
Gerwien J; Nielsen M; Labuda T; Nissen MH; Svejgaard A; Geisler C; Röpke C; Odum N
J Immunol; 1999 Aug; 163(4):1742-5. PubMed ID: 10438903
[TBL] [Abstract][Full Text] [Related]
23. Alterations in T-cell signal transduction molecules associated with recurrent spontaneous pregnancy loss.
Taylor DD; Gercel-Taylor C
J Reprod Immunol; 2004 Oct; 63(2):137-54. PubMed ID: 15380944
[TBL] [Abstract][Full Text] [Related]
24. Requirement for distinct Janus kinases and STAT proteins in T cell proliferation versus IFN-gamma production following IL-12 stimulation.
Ahn HJ; Tomura M; Yu WG; Iwasaki M; Park WR; Hamaoka T; Fujiwara H
J Immunol; 1998 Dec; 161(11):5893-900. PubMed ID: 9834069
[TBL] [Abstract][Full Text] [Related]
25. HIV-1 glycoprotein gp120 disrupts CD4-p56lck/CD3-T cell receptor interactions and inhibits CD3 signaling.
Hubert P; Bismuth G; Körner M; Debré P
Eur J Immunol; 1995 May; 25(5):1417-25. PubMed ID: 7774645
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of IL-2-induced Jak-STAT signaling by glucocorticoids.
Bianchi M; Meng C; Ivashkiv LB
Proc Natl Acad Sci U S A; 2000 Aug; 97(17):9573-8. PubMed ID: 10920190
[TBL] [Abstract][Full Text] [Related]
27. The molecular mechanism of curcumol on inducing cell growth arrest and apoptosis in Jurkat cells, a model of CD4⁺ T cells.
Wang H; Wang Y; Jiang X; Wang Z; Zhong B; Fang Y
Int Immunopharmacol; 2014 Aug; 21(2):375-82. PubMed ID: 24877754
[TBL] [Abstract][Full Text] [Related]
28. The effects of CD3, CD4 and CD28 signaling on lymphocytes during human immunodeficiency virus-1 infection.
Guntermann C; Zheng R; Nye KE
Eur J Immunol; 1997 Aug; 27(8):1966-72. PubMed ID: 9295033
[TBL] [Abstract][Full Text] [Related]
29. Convergence of signaling transduced by prolactin (PRL)/cytokine chimeric receptors on PRL-responsive gene transcription.
Ferrag F; Chiarenza A; Goffin V; Kelly PA
Mol Endocrinol; 1996 Apr; 10(4):451-60. PubMed ID: 8721989
[TBL] [Abstract][Full Text] [Related]
30. Human lung myofibroblasts as effectors of the inflammatory process: the common receptor gamma chain is induced by Th2 cytokines, and CD40 ligand is induced by lipopolysaccharide, thrombin and TNF-alpha.
Doucet C; Giron-Michel J; Canonica GW; Azzarone B
Eur J Immunol; 2002 Sep; 32(9):2437-49. PubMed ID: 12207328
[TBL] [Abstract][Full Text] [Related]
31. MHC class I ligation of human T cells activates the ZAP70 and p56lck tyrosine kinases, leads to an alternative phenotype of the TCR/CD3 zeta-chain, and induces apoptosis.
Skov S; Bregenholt S; Claesson MH
J Immunol; 1997 Apr; 158(7):3189-96. PubMed ID: 9120273
[TBL] [Abstract][Full Text] [Related]
32. Interleukin-2 (IL-2) receptor-betagamma signalling is activated by c-Kit in the absence of IL-2, or by exogenous IL-2 via JAK3/STAT5 in human papillomavirus-associated cervical cancer.
Rocha-Zavaleta L; Huitron C; Cacéres-Cortés JR; Alvarado-Moreno JA; Valle-Mendiola A; Soto-Cruz I; Weiss-Steider B; Rangel-Corona R
Cell Signal; 2004 Nov; 16(11):1239-47. PubMed ID: 15337523
[TBL] [Abstract][Full Text] [Related]
33. Tumor-induced suppression of T lymphocyte proliferation coincides with inhibition of Jak3 expression and IL-2 receptor signaling: role of soluble products from human renal cell carcinomas.
Kolenko V; Wang Q; Riedy MC; O'Shea J; Ritz J; Cathcart MK; Rayman P; Tubbs R; Edinger M; Novick A; Bukowski R; Finke J
J Immunol; 1997 Sep; 159(6):3057-67. PubMed ID: 9300731
[TBL] [Abstract][Full Text] [Related]
34. TGF-beta inhibits IL-2-induced tyrosine phosphorylation and activation of Jak-1 and Stat 5 in T lymphocytes.
Bright JJ; Kerr LD; Sriram S
J Immunol; 1997 Jul; 159(1):175-83. PubMed ID: 9200453
[TBL] [Abstract][Full Text] [Related]
35. Signaling via IL-2 and IL-4 in JAK3-deficient severe combined immunodeficiency lymphocytes: JAK3-dependent and independent pathways.
Oakes SA; Candotti F; Johnston JA; Chen YQ; Ryan JJ; Taylor N; Liu X; Hennighausen L; Notarangelo LD; Paul WE; Blaese RM; O'Shea JJ
Immunity; 1996 Dec; 5(6):605-15. PubMed ID: 8986719
[TBL] [Abstract][Full Text] [Related]
36. An alternative pathway for STAT activation that is mediated by the direct interaction between JAK and STAT.
Fujitani Y; Hibi M; Fukada T; Takahashi-Tezuka M; Yoshida H; Yamaguchi T; Sugiyama K; Yamanaka Y; Nakajima K; Hirano T
Oncogene; 1997 Feb; 14(7):751-61. PubMed ID: 9047382
[TBL] [Abstract][Full Text] [Related]
37. Neuregulin-1 activates the JAK-STAT pathway and regulates lung epithelial cell proliferation.
Liu J; Kern JA
Am J Respir Cell Mol Biol; 2002 Sep; 27(3):306-13. PubMed ID: 12204892
[TBL] [Abstract][Full Text] [Related]
38. IL-4 selectively inhibits IL-2-triggered Stat5 activation, but not proliferation, in human T cells.
Castro A; Sengupta TK; Ruiz DC; Yang E; Ivashkiv LB
J Immunol; 1999 Feb; 162(3):1261-9. PubMed ID: 9973378
[TBL] [Abstract][Full Text] [Related]
39. Distinct tyrosine phosphorylation sites in JAK3 kinase domain positively and negatively regulate its enzymatic activity.
Zhou YJ; Hanson EP; Chen YQ; Magnuson K; Chen M; Swann PG; Wange RL; Changelian PS; O'Shea JJ
Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13850-5. PubMed ID: 9391116
[TBL] [Abstract][Full Text] [Related]
40. Interferon-alpha inhibits Stat5 DNA-binding in IL-2 stimulated primary T-lymphocytes.
Erickson S; Matikainen S; Thyrell L; Sangfelt O; Julkunen I; Einhorn S; Grandér D
Eur J Biochem; 2002 Jan; 269(1):29-37. PubMed ID: 11784295
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
